The compound (1) of the formula is as follows. It also describes the use of these compounds in the treatment of new tumor diseases or immune diseases. 1. Claim 1: a formula compound (1), characterized by: each X1 and X2 is independent, halogenated or os8322；； r749191；where Rᵃ is alkyl, alkenyl or alkynyl； Q is cycloalkyl, cycloalkenyl, heterocycloalkenyl, aryl or heteroaryl, each of which, independently, is optionally substituted by alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, heterocycloalkenyl, aryl, heteroaryl, halo, nitro, oxo, -CH = NH, cyano, alkyl-Rᵇ,CH = NORᵇ,Or74955,OC (O) ROC (O) OROC (O) SR74955,C (O) RC (O) ORC (O) SRC (o) No. 7580； r74966；Sor74955,SO₂Rᵇ,No. 7580； No. 74966；1. Asphalt-nr7580； r7496o n (r758080) C (o) r74966；Every r74955 there,R7580 and r74966,independently, it is H, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, cyano, nitro, amino, hydroxyl, alkylamino, haloalkyl or alkoxy； Z is eliminated or is (CH₂) ₘ where m is an integer from 1 to 10； and each of R¹ and R² independently, is H, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, heterocycloalkenyl, aryl, heteroaryl, halo, nitro, oxo, -CH = NH, cyano, alkyl-Rᵇ,CH = NORᵇ,Or74955,OC (O) ROC (O) OROC (O) SR74955,C (O) RC (O) ORC (O) SRC (o) No. 7580； r74966；Sor74955,SO₂Rᵇ,No. 7580； No. 74966；1. Asphalt-nr7580； r7496o n (r758080) C (o) r7496；Se describe el compuesto de la formula (1). También se describe un método para tratar una enfermedad neoplásica o una enfermedad inmunitaria con estos compuestos. Reivindicación 1: Un compuesto de fórmula (1) caracterizado porque: cada uno de X¹ y X² independientemente, es halo o OSO₂Rᵃ, donde Rᵃ es alquilo, alquenilo o alquinilo； Q es cicloalquilo, cicloalquenilo, heterocicloalquenilo, arilo o heteroarilo, cada uno de los cuales, independientemente, está opcionalmente sustituido por alquilo, alquenilo, alquinilo, cicloalquilo, heterocicloalquilo, cicloalquenilo, heterocicloalq
